GTHP (GTHP) Stock Price & Analysis
GTHP (GTHP) rose 0.00% to USD 0.2 as of September 8, 2026 at 14:07 UTC, according to Nexqual real-time market data.
GTHP last closed at USD 0.2; the session ranged USD 0.2–0.2 on volume of 2,500 shares. Market capitalization is —, with a 52-week range of USD 0.15–0.54 (OQB). Source: Nexqual, September 8, 2026 at 14:07 UTC.
Key Statistics (as of September 8, 2026 at 14:07 UTC)
| Price | USD 0.2 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.2 |
| Open | USD 0.2 |
| Day Range | USD 0.2 – 0.2 |
| 52-Week Range | USD 0.15 – 0.54 |
| Volume | 2,500 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (GTHP)
Nexqual's technical model rates GTHP "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:07 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.24 (neutral) |
| vs SMA50 | Below (USD 0.26) |
| MACD | -0.02 (negative) |
From GTHP's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BICX | BioCorRx Inc. | USD 0.2 | ▼ 4.29% |
| RGRX | REGENERX BIOPHARMACEUTICALS | USD 0 | ▲ 0% |
| NEPH | Nephros, Inc. | USD 4.28 | ▲ 2.39% |
| AMBS | Amarantus Bioscience Holdings, | USD 0 | ▲ 0% |
| LLBO | Lifeline BioTechnologies, Inc. | USD 0 | ▲ 60% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:07 UTC. This page is informational and not investment advice.